2019. Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE). Reumatismo. 71, 1 (Apr. 2019), 24–30. DOI:https://doi.org/10.4081/reumatismo.2019.1154.